Tumor Progression Locus 2 (Map3k8) Is Critical for Host Defense against <i>Listeria monocytogenes</i> and IL-1β Production

Lisa A. Mielke(National Institutes of Health), Wendy T. Watford(National Institutes of Health)

The Journal of Immunology

November 23, 2009

10.4049/jimmunol.0901336

Cited by 96

Related Papers

Ablation of Tumor Progression Locus 2 Promotes a Type 2 Th Cell Response in Ovalbumin-Immunized Mice

|The Journal of Immunology|2009|38

Tumor Progression Locus 2-dependent Oxidative Burst Drives Phosphorylation of Extracellular Signal-regulated Kinase during TLR3 and 9 Signaling

|Journal of Biological Chemistry|2014|21

Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus

|PLoS Pathogens|2015|19

Tumor Progression Locus 2 Differentially Regulates IFNγ and IL-17 Production by Effector CD4+ T Cells in a T Cell Transfer Model of Colitis

|PLoS ONE|2015|9